Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 known ✓ | P12268 | 2/20 | 0.96 |
| ▸ | IMPDH1 known ✓ | P20839 | 1/20 | 0.96 |
| ▸ | PRKD3 known ✓ | O94806 | 1/20 | 0.43 |
| ▸ | ABL1 known ✓ | P00519 | 1/20 | 0.43 |
| ▸ | PRKCG known ✓ | P05129 | 1/20 | 0.43 |
| ▸ | PRKCB known ✓ | P05771 | 1/20 | 0.43 |
| ▸ | CDK4 known ✓ | P11802 | 1/20 | 0.43 |
| ▸ | PRKCA known ✓ | P17252 | 1/20 | 0.43 |
| ▸ | PRKCH known ✓ | P24723 | 1/20 | 0.43 |
| ▸ | PRKCI known ✓ | P41743 | 1/20 | 0.43 |
| ▸ | PRKCE known ✓ | Q02156 | 1/20 | 0.43 |
| ▸ | PRKCQ known ✓ | Q04759 | 1/20 | 0.43 |
| ▸ | PRKCZ known ✓ | Q05513 | 1/20 | 0.43 |
| ▸ | PRKCD known ✓ | Q05655 | 1/20 | 0.43 |
| ▸ | PRKD1 known ✓ | Q15139 | 1/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.52 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7431978 | 1.00 | IMPDH2 (0.96) | IMPDH2IMPDH1DYRK1ALRRK2APP | |
| SCHEMBL29820843 | 0.98 | IMPDH2 (1.00) | IMPDH2IMPDH1DYRK1ALRRK2APP | |
| SCHEMBL186741 | 0.98 | IMPDH2 (1.00) | IMPDH2IMPDH1DYRK1ALRRK2APP | |
| SCHEMBL28328494 | 0.96 | IMPDH2 (0.96) | IMPDH2IMPDH1DYRK1ALRRK2APP | |
| SCHEMBL5010332 | 0.82 | IMPDH2 (0.72) | IMPDH2IMPDH1DYRK1ALRRK2APP | |
| 1-Naphthol SCHEMBL28171602 | 0.82 | IMPDH2 (0.70) | IMPDH2IMPDH1DYRK1ALRRK2APP | |
| SCHEMBL17506602 | 0.80 | IMPDH2 (0.69) | IMPDH2IMPDH1APPATMGPR84 | |
| SCHEMBL5931727 | 0.78 | IMPDH2 (0.67) | IMPDH2IMPDH1AHRPRKCQ | |
| SCHEMBL28602064 | 0.78 | IMPDH2 (0.64) | IMPDH2IMPDH1DYRK1ALRRK2MEN1 | |
| SCHEMBL30608285 | 0.77 | IMPDH2 (0.65) | IMPDH2IMPDH1APPMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1070051-B1 | PROCESS FOR THE PRODUCTION OF R-(+)-6- CARBOXAMIDO- 3-N- METHYLAMINO- 1,2,3,4- TETRAHYDROCARBAZOLE | VERNALIS DEV LTD (GB) | 2015-06-03 | — | — | EP | disclosed |
| CN-1200931-C | Preparation method of R- (+) -6-formamido-3-N-methylamino-1, 2,3, 4-tetrahydrocarbazole | FINARIS CO LTD (GB) | 2005-05-11 | — | — | CN | disclosed |
| US-6359146-B1 | RESOLUTION OF ENANTIOMORPH MIXTURE | VERNALIS LIMITED (GB) | 2002-03-19 | — | — | US | disclosed |
| CN-1305460-A | Process for preparation of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole | FINARIS CO LTD (GB) | 2001-07-25 | — | — | CN | disclosed |
| EP-1070051-A1 | PROCESS FOR THE PRODUCTION OF R-(+)-6- CARBOXAMIDO- 3-N- METHYLAMINO- 1,2,3,4- TETRAHYDROCARBAZOLE | Vernalis Limited (GB) | 2001-01-24 | — | — | EP | disclosed |
| WO-1999054302-A1 | PROCESS FOR THE PRODUCTION OF R-(+)-6- CARBOXAMIDO- 3-N- METHYLAMINO- 1,2,3,4- TETRAHYDROCARBAZOLE | VERNALIS LIMITED (GB) | 1999-10-28 | — | — | WO | disclosed |